Clinical Trials Logo

Clinical Trial Summary

The study is designed to evaluate the value of ctDNA in predicting the drug efficacy of chemotherapy for metastatic colorectal cancer.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04555369
Study type Interventional
Source Fudan University
Contact Weijian Guo, phD
Phone 8621-64175590
Email iamchangjinjia@163.com
Status Recruiting
Phase N/A
Start date September 23, 2020
Completion date September 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05167604 - Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC
Recruiting NCT05598528 - Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
Not yet recruiting NCT03688035 - Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
Not yet recruiting NCT05027828 - CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer
Recruiting NCT03737539 - Dynamic Monitoring of ctDNA Methylation to Predict Relapse in Colorectal Cancer After Radical Resection (POSTCA)
Not yet recruiting NCT04511559 - Methylation Analysis of Circulating Tumor DNA in Gastric Cancer
Recruiting NCT03748680 - IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer Phase 2
Completed NCT02620527 - Concordance Between ctDNA Assay and FoundationOne
Recruiting NCT05529615 - Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer N/A
Recruiting NCT05601505 - Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer Phase 2
Recruiting NCT05161585 - Evaluation of Circulating Tumor DNA Guided Surveillance Strategy of Stage III Colorectal Cancer: an Open, Prospective, Randomized Controlled Cohort Study N/A
Recruiting NCT05390112 - Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of Chemoembolization
Recruiting NCT04966663 - Using ctDNA to Determine Therapies for Lung Cancer Phase 2
Recruiting NCT05801263 - ctDNA Methylation for Epithelial Ovarian Cancer
Recruiting NCT05801276 - ctDNA Methylation for Detecting Ovarian Cancer
Active, not recruiting NCT04276337 - Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy
Recruiting NCT05969938 - Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology
Completed NCT04456972 - Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers. N/A
Completed NCT03750175 - OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer -
Recruiting NCT04457297 - Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection Phase 3